Louise E. Sivak

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text

Multiple congenital anomalies in a man with (X;6) translocation

Louise E. Sivak, John H. Esbenshade, Arthur R. Brothman et al. · American Journal of Medical Genetics · 1994 · 78 citations

Expression of the c-Myc Protein in Childhood Medulloblastoma

Carol S. Bruggers, Kuei-Fang Tai, Todd J. Murdock et al. · Journal of Pediatric Hematology/Oncology · 1998 · 60 citations

Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines

Louise E. Sivak, Kuei‐Fang Tai, Robin S Smith et al. · Oncogene · 1997 · 31 citations

Cell Regulation, Oncogenic Agent, Immunology +5

A Novel Intron Element Operates Posttranscriptionally To Regulate Human N-<i>myc</i> Expression

Louise E. Sivak, Geneviève Pont-Kingdon, Kim Le et al. · Molecular and Cellular Biology · 1999 · 26 citations · Full text